A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 Diabetes
Clinical trial NCT03315780 · COMPLETED
Trial details
- NCT number
- NCT03315780
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-28
- Primary completion
- 2018-02-28
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.